ClinicalTrials.gg
RecruitingNCT01571531Updated Sep 25, 2026

European Multicentre Study of Human Spinal Cord Injury

An observational study in Spinal Cord Injury, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by University of Zurich · Observational

How we know

From the registry’s dates

  • Started Apr 2004; still recruiting 22 years 7 months later.
Updated Sep 25, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
8,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Spinal Cord Injuries by University of Zurich — 7 open to participants now, 7 under way, none of them phase 3. Spinal Cord Injuries · University of Zurich.

Planned enrollment
Largest of 10
8,000 · median 204
Started
2004
the only one that year
Observational
10 of 24
4 open now
Registered
3rd of 24
by date

Among the 24 studies in Spinal Cord Injuries by University of Zurich, this one has the largest planned enrollment of the 10 observational ones that give a count, is the only one that started in 2004, is one of 10 observational ones, and was the 3rd registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

7 of the 24 studies in Spinal Cord Injuries by University of Zurich are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Spinal Cord Injuries by University of Zurich, or all of them as a file.
02

Study summary

Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge about the natural recovery after spinal cord lesion in a larger population of patients in the sense of a historical control group and to bring new standardised assessment tools to the clinical setting.

03

Conditions studied

  • Spinal Cord Injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

primary care clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Single event traumatic or ischemic para- or tetraplegia
  • First EMSCI assessment possible within the first 6 weeks after incidence
  • Patient capable and willing of giving written

Exclusion criteria

Exclusion Criteria:

  • Nontraumatic para- or tetraplegia (i.e. discusprolaps, tumor, AV-malformation, myelitis) excl. single event ischemic incidences
  • Pre-known dementia or severe reduction of intelligence, leading to reduced capabilities of cooperation or giving consent
  • Peripheral nerve lesions above the level of lesion (i.e. plexus brachialis impairment)
  • Pre-known polyneuropathy
  • Severe craniocerebral injury
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
8,000 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Spinal Cord Independence Measure (SCIM)

    Score from 0 to 100 points; the higher the score, the higher the independence of the patient

    Time frame: Change in course from 2 weeks at 48 weeks

  2. International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI score)

    Score from 0 to 112; the higher the score, the better the neurological status of the patient

    Time frame: Change in course from 2 weeks at 48 weeks

  3. Walking Index for Spinal Cord Injury (WISCI)

    Score from 0 to 20; the higher the score, the better the walking ability of the patient

    Time frame: Change in course from 2 weeks at 48 weeks

  4. 10 Meter Walk Test (10mWT)

    Time frame: Change in course from 2 weeks at 48 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Pavese C, Scivoletto G, Puci M, Rupp R, Schubert M, Rohrich F, Waldmann J, Weidner N, Kalke YB, Abel R, Maier D, Kriz J, Chhabra HS, Rehahn K, Montomoli C, Curt A, Jutzeler CR. The Relationship Between Age and Recovery After Spinal Cord Injury: A Longitudinal Cohort Study. Neurology. 2026 Jan 27;106(2):e214516. doi: 10.1212/WNL.0000000000214516. Epub 2025 Dec 23. PubMed 41428979 ↗
  • Sliwinski C, Heutehaus L, Taberner FJ, Weiss L, Kampanis V, Tolou-Dabbaghian B, Cheng X, Motsch M, Heppenstall PA, Kuner R, Franz S, Lechner SG, Weidner N, Puttagunta R. Contribution of mechanoreceptors to spinal cord injury-induced mechanical allodynia. Pain. 2024 Jun 1;165(6):1336-1347. doi: 10.1097/j.pain.0000000000003139. Epub 2023 Dec 27. PubMed 38739766 ↗
  • Jende JME, Heutehaus L, Preisner F, Verez Sola CM, Mooshage CM, Heiland S, Rupp R, Bendszus M, Weidner N, Kurz FT, Franz S. Magnetic resonance neurography in spinal cord injury: Imaging findings and clinical significance. Eur J Neurol. 2024 Apr;31(4):e16198. doi: 10.1111/ene.16198. Epub 2024 Jan 18. PubMed 38235932 ↗
  • Pavese C, Scivoletto G, Puci MV, Abel R, Curt A, Maier D, Rupp R, Schubert M, Weidner N, Montomoli C, Kessler TM. Prediction of bowel management independence after ischemic spinal cord injury. Eur J Phys Rehabil Med. 2022 Oct;58(5):709-714. doi: 10.23736/S1973-9087.22.07366-X. Epub 2022 Jun 6. PubMed 35666490 ↗
  • Franz S, Rust L, Heutehaus L, Rupp R, Schuld C, Weidner N. Impact of Heterotopic Ossification on Functional Recovery in Acute Spinal Cord Injury. Front Cell Neurosci. 2022 Feb 9;16:842090. doi: 10.3389/fncel.2022.842090. eCollection 2022. PubMed 35221928 ↗
  • Buri M, Curt A, Steeves J, Hothorn T. Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes. BMC Med Res Methodol. 2020 May 6;20(1):104. doi: 10.1186/s12874-020-00984-2. PubMed 32375705 ↗

Related links

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2004 (actual). Primary completion is estimated for Dec 2026, 272 months after the start.

Of 124 non-industry observational studies under Spinal Cord Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 74. This study's planned 272 months is above that.

Counting every sponsor, half of 135 studies reached it within 39 months; a quarter within 16 and three quarters within 82.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 25, 2026: primary completion Aug 2026 → Dec 2026 and completion Aug 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2012
First posted
Apr 5, 2012
StartActual
Apr 2004
Primary completionEst.
Dec 2026was Aug 2026
CompletionEst.
Dec 2026was Aug 2026
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 2026→Dec 2026
Sep 25, 2026
Study completion
Aug 2026→Dec 2026
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Primary completion Aug 2026→Dec 2026
    Study completion Aug 2026→Dec 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT01571531
Responsible party
Sponsor
First posted
Apr 5, 2012
Start date
Apr 2004
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Sep 25, 2026

Study contacts

Armin Curt, Prof., MD
Contact
armin.curt@balgrist.ch
+41 44 386 39 01
Martin Schubert, MD
Contact
martin.schubert@balgrist.ch
+41 44 386 39 45
Armin Curt, Prof., MD
principal investigator · University of Zurich
Martin Schubert, MD
study director · University of Zurich

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion